Atossa Therapeutics, Inc. (ATOS)
2.56
+0.14
(+5.79%)
USD |
NASDAQ |
Oct 09, 10:20
Atossa Therapeutics Market Cap : 25.55M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 24.15M |
| October 07, 2026 | 24.55M |
| October 06, 2026 | 24.45M |
| October 05, 2026 | 24.45M |
| October 02, 2026 | 23.35M |
| October 01, 2026 | 22.65M |
| September 30, 2026 | 19.46M |
| September 29, 2026 | 19.86M |
| September 28, 2026 | 19.56M |
| September 25, 2026 | 18.96M |
| September 24, 2026 | 20.46M |
| September 23, 2026 | 21.75M |
| September 22, 2026 | 22.55M |
| September 21, 2026 | 22.45M |
| September 18, 2026 | 22.15M |
| September 17, 2026 | 23.95M |
| September 16, 2026 | 24.15M |
| September 15, 2026 | 23.65M |
| September 14, 2026 | 24.75M |
| September 11, 2026 | 25.05M |
| September 10, 2026 | 23.35M |
| September 09, 2026 | 23.95M |
| September 08, 2026 | 25.10M |
| September 04, 2026 | 25.15M |
| September 03, 2026 | 25.25M |
| Date | Value |
|---|---|
| September 02, 2026 | 24.55M |
| September 01, 2026 | 24.15M |
| August 31, 2026 | 24.95M |
| August 28, 2026 | 25.75M |
| August 27, 2026 | 26.35M |
| August 26, 2026 | 26.45M |
| August 25, 2026 | 26.74M |
| August 24, 2026 | 26.35M |
| August 21, 2026 | 25.35M |
| August 20, 2026 | 25.85M |
| August 19, 2026 | 26.35M |
| August 18, 2026 | 25.85M |
| August 17, 2026 | 27.84M |
| August 14, 2026 | 25.95M |
| August 13, 2026 | 25.55M |
| August 12, 2026 | 23.45M |
| August 11, 2026 | 23.55M |
| August 10, 2026 | 23.65M |
| August 07, 2026 | 23.55M |
| August 06, 2026 | 24.15M |
| August 05, 2026 | 23.85M |
| August 04, 2026 | 19.89M |
| August 03, 2026 | 18.69M |
| July 31, 2026 | 17.83M |
| July 30, 2026 | 18.86M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Immix Biopharma, Inc. | 667.43M |
| ACADIA Pharmaceuticals, Inc. | 3.415B |
| Alnylam Pharmaceuticals, Inc. | 30.90B |
| Savara, Inc. | 1.009B |
| Vericel Corp. | 2.087B |
Market Cap Related Metrics
| PEG Ratio | -0.0043 |
| Price to Book Value | 0.9522 |
| Price | 2.56 |
| Earnings Yield | -169.7% |
| PEGY Ratio | -0.0043 |